PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Faubel Becomes CCL Faubel

The Faubel Group now operates under a new name following its takeover by CCL Industries Inc.

Since August 2023, CCL Industries Inc. has held all shares in the Faubel Group, which officially changed its name to CCL Faubel at the beginning of 2024. With this acquisition, CCL, the world’s largest label manufacturer, is expanding its organizational and operational capabilities in the healthcare sector to the European market. CCL Faubel’s headquarters shall remain in Melsungen.

CCL Industries Inc. employs over 25,000 people at 204 production sites in 43 countries. In 2022, the listed Group generated a total of 6.4 billion Canadian dollars, which equates to approximately 4.4 billion euros. CCL Faubel Managing Director Frank Jäger emphasized that “although CCL Faubel only makes up a small part of the Group as an individual company, our special knowledge is unique. As long as we can maintain this advantage, I can expect sustainable growth for CCL Faubel”.

Caption: At a strategy meeting in Melsungen, Lee Pretsell (right), Group Vice President of Healthcare and Specialty Worldwide at CCL Label, met with the CCL Faubel management team, Frank Jäger, Frank Ludwig and Martin Kuge (from left to right).

CCL Faubel GmbH:

CCL Faubel GmbH was formed at the end of 2023 following the acquisition of the Faubel Group by CCL Industries Inc. CCL Faubel is now part of the world’s largest label manufacturer and produces labels for the pharmaceutical and logistics industries in particular. Its product portfolio encompasses paper and film labels alongside Smart Labels featuring e-paper and RFID technology.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026